HR 5309, the Congressional Tribute to Constance Baker Motley Act of 2025, authorizes a posthumous Congressional gold medal for Constance Baker Motley, a pioneering civil rights attorney and judge. The bill directs the Treasury Secretary to strike the medal with her image and name, to be presented to her son, Joel W. Motley III, and her niece, Constance Royster. It also permits the sale of bronze duplicates at cost to cover expenses, with proceeds going to the U.S. Mint fund. This is a commemorative measure with no substantive policy changes, honoring Motley’s legacy as the first African-American woman appointed to a federal judgeship.
The LINE Act (HR 5319) prohibits the Centers for Medicare and Medicaid Services (CMS) and the Department of Health and Human Services (HHS) from sharing Medicaid health data with U.S. Immigration and Customs Enforcement (ICE). Specifically, it blocks the disclosure of individually identifiable health information from Medicaid enrollment records (under Title XIX of the Social Security Act) to ICE for immigration enforcement purposes. This directly affects Medicaid enrollees, particularly those who may be immigrants, by preventing their health data from being used in immigration proceedings. The law creates a clear barrier between Medicaid health records and immigration enforcement efforts.
HR 5340 prohibits the U.S. Department of Housing and Urban Development (HUD) and public housing agencies from sharing tenant records with immigration authorities for immigration enforcement purposes. It directly affects all HUD housing program participants (including renters and applicants, regardless of immigration status) by requiring HUD to obtain written consent or a language-proficient request from the individual before disclosing their records. Key provisions include banning disclosure without consent, preventing HUD from forcing public housing agencies to share records, and mandating a 90-day compliance report to Congress detailing record security and past sharing practices. The bill aims to protect housing privacy by ensuring immigration enforcement cannot access sensitive tenant information held by HUD without explicit individual authorization.
HRES 697 is a symbolic House resolution recognizing suicide as a preventable public health issue and supporting the designation of September as "National Suicide Prevention Month" and September 10, 2025, as "World Suicide Prevention Day." It does not create new laws or allocate funds but formally expresses congressional support for these designations to raise awareness. The resolution cites statistics showing suicide as a leading cause of death across age groups, including among veterans and adolescents, and emphasizes mental health as equally important as physical health. It acknowledges the need for diverse prevention strategies without specifying new policies or programs. This resolution is purely declarative, aiming to bolster public awareness rather than enact concrete changes.
HRES 695 is a commemorative resolution honoring Charlie Kirk, a conservative speaker and Turning Point USA leader, following his assassination on September 10, 2025, in Orem, Utah. The resolution condemns the attack, offers condolences to his family, and recognizes first responders. It reaffirms the First Amendment right to peaceful assembly and emphasizes that violence cannot silence democratic participation. This non-binding resolution does not create new laws or policies but serves as a symbolic tribute to Kirk's memory and the principles of democratic engagement.
This resolution (HRES 691) commemorates the 135th anniversary of the 1890 Institutions - 19 historically Black land-grant universities established under the 1890 Morrill Act - to be observed on August 30, 2025. It recognizes these institutions’ 135 years of contributions to agricultural education, research, and extension, serving over 88,000 students in fields like STEM and agriculture. The resolution encourages federal and state ceremonies to celebrate their work and supports continued partnership with the USDA, though it does not create new funding or policy changes. It is a non-binding expression of congressional support for these institutions’ historical and ongoing mission.
This resolution designates September 9 as "National African Immigrant and Refugee HIV/AIDS and Hepatitis Awareness Day" (NAIRHHA Day). It directly supports African immigrant and refugee communities in the U.S., which face significantly higher rates of HIV (6x the general population) and hepatitis B (10% prevalence) compared to other groups. The resolution expresses support for raising awareness about these health disparities, reducing stigma, and promoting culturally appropriate prevention, testing, and treatment resources. It is a non-binding symbolic gesture by the House of Representatives, not a policy with new requirements or funding.
The RESULTS Act (S 2761) changes how Medicare sets payment rates for clinical diagnostic laboratory tests by requiring the collection of final payment data from private payors through a qualifying comprehensive claims database. For widely available non-ADLT tests (non-Advanced Diagnostic Laboratory Tests), this new system will apply to data collection periods beginning January 1, 2027, with reporting for these periods starting January 1, 2028. If data isn't available for a test, the bill establishes a default payment rate equal to the previous year's rate adjusted for inflation. This affects Medicare, clinical laboratories, and private payors by creating more accurate, market-based payment rates that better reflect final payments made by private insurers.
This bill would make several administrative changes to the Social Security Administration, including exempting it from the jurisdiction of the Department of Government Efficiency (DOGE) and certain executive orders, restricting political appointees from accessing beneficiary data systems, and preventing closure of field offices while requiring maintenance of staff levels. It also creates new offices within the SSA for civil rights, transformation, and analytics, and provides additional funding for administrative costs and customer experience improvements. These provisions would directly affect how the SSA manages its operations, protects beneficiary data, and delivers services to beneficiaries. The bill's title is misleading as it does not address billionaires or their relationship with Social Security.
HR 5278, the Affordable Inhalers and Nebulizers Act of 2025, limits out-of-pocket costs for patients using prescription inhalers and nebulizers to treat asthma and chronic obstructive pulmonary disease (COPD). The bill requires private health insurance plans, Medicare Part B and Part D, and new payment programs to cover these products with no deductible and a maximum cost of $15 per 30-day supply. It directly affects patients with asthma or COPD who rely on covered inhalers, nebulizers, and related equipment like spacers. The law applies to all specified inhaler products (including medications and administration equipment) and takes effect for plan years beginning January 1, 2026.
The RESULTS Act (HR 5269) changes how Medicare calculates payment rates for clinical diagnostic laboratory tests. It requires Medicare to collect data on private payor rates for widely available non-Advanced Diagnostic Laboratory Tests (non-ADLTs) from a qualifying independent claims data entity (a national nonprofit organization meeting specific criteria) rather than relying on data reported directly by laboratories. For tests where data is unavailable, the bill establishes default payment rates based on previous years' rates adjusted for inflation. The law also requires Medicare to publicly explain payment rates with supporting data, affecting Medicare beneficiaries, clinical laboratories, and private payors that provide services covered by Medicare.
The 340B ACCESS Act strengthens oversight of the 340B Drug Pricing Program, which allows safety-net hospitals and clinics to purchase outpatient drugs at discounted prices. The bill clarifies who qualifies as a "patient" for 340B discounts, establishes new requirements for hospital child sites and contract pharmacies, and mandates that covered entities implement sliding fee scales to ensure patient affordability based on income. It creates a claims data clearinghouse to prevent duplicate Medicaid discounts and requires covered entities to report detailed data about drug dispensing. These changes aim to ensure 340B discounts reach intended patients while preventing program misuse and ensuring transparency.
